Joana Paula Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joana Paula Silva has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Annemieke Benschop
Bonger Institute, University of Amsterdam, Amsterdam, Netherlands
2 shared publications - Bernd Werse
Institut für Sozialpädagogik und Erwachsenenbildung, Centre for Drug Research, Frankfurt a. M
2 shared publications - Dirk J. Korf
University of Amsterdam
2 shared publications - Gerrit Kamphausen
Goethe-Universität Frankfurt
2 shared publications - Katalin Felvinczi
Institute of Psychology, Eötvös Loránd University, Budapest, Hungary
2 shared publications - Katarzyna Dąbrowska
Institute of Psychiatry and Neurology, Warsaw, Poland
2 shared publications
Latest Publications
- Open Access
- 17 December 2018
- Published by Springer Nature in International Journal of Mental Health and Addiction
- Vol. 17 (5) , 1237-1251
Sharing, Group-Buying, Social Supply, Offline and Online Dealers: how Users in a Sample from Six European Countries Procure New Psychoactive Substances (NPS)
- 17 December 2018
- Published by Springer Nature in International Journal of Mental Health and Addiction
- Vol. 17 (5) , 1237-1251
Open AccessSharing, Group-Buying, Social Supply, Offline and Online Dealers: how Users in a Sample from Six European Countries Procure New Psychoactive Substances (NPS)
- Open Access
- 7 December 2017
- Published by Springer Nature in International Journal of Mental Health and Addiction
- Vol. 16 (2) , 480-495
Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a public health challenge. The study describes health and social consequences of recent NPS use as reported in a survey of marginalised, nightlife and online NPS users in the Netherlands, Hungary, Portugal, Ireland, Germany and Poland (n = 3023). Some respondents were unable to categorise NPS they had used. Use of ‘herbal blends’ and ‘synthetic cannabinoids obtained pure’ was most reported in Germany, Poland and Hungary, and use of ‘branded stimulants’ and ‘stimulants/empathogens/nootropics obtained pure’ was most reported in the Netherlands. Increased heart rate and palpitation, dizziness, anxiety, horror trips and headaches were most commonly reported acute side effects. Marginalised users reported substantially more acute side effects, more mid- and long-term mental and physical problems, and more social problems. Development of country-specific NPS awareness raising initiatives, health and social service needs assessments, and targeted responses are warranted.
- 7 December 2017
- Published by Springer Nature in International Journal of Mental Health and Addiction
- Vol. 16 (2) , 480-495
Open AccessHealth and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a public health challenge. The study describes health and social consequences of recent NPS use as reported in a survey of marginalised, nightlife and online NPS users in the Netherlands, Hungary, Portugal, Ireland, Germany and Poland (n = 3023). Some respondents were unable to categorise NPS they had used. Use of ‘herbal blends’ and ‘synthetic cannabinoids obtained pure’ was most reported in Germany, Poland and Hungary, and use of ‘branded stimulants’ and ‘stimulants/empathogens/nootropics obtained pure’ was most reported in the Netherlands. Increased heart rate and palpitation, dizziness, anxiety, horror trips and headaches were most commonly reported acute side effects. Marginalised users reported substantially more acute side effects, more mid- and long-term mental and physical problems, and more social problems. Development of country-specific NPS awareness raising initiatives, health and social service needs assessments, and targeted responses are warranted.